세계의 근골격계 질환 제네릭 의약품 시장 보고서(2023년)

“Generic Musculoskeletal Disorders Drugs Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generic musculoskeletal disorders drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generic musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The generic musculoskeletal disorders drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment Type: Medication; Therapy; Surgery; Other Treatment Types

• 2) By Route of Administration: Oral; Parenteral; Other Routes

• 3) By Disorder Type: Osteoarthritis; Rheumatoid Arthritis; Spondylarthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Fibromyalgia; Other Disorder Types

• 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Drug Store; Online Pharmacy

• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Eli Lilly And Company; Ampio Pharmaceuticals Inc.; Amgen Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the generic musculoskeletal disorders drugs market are Pfizer Inc., Sanofi S.A., Eli Lilly And Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca Plc., Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics Plc., Procter & Gamble, Eisai Co. Ltd., Biogen Inc., and Sino Biopharmaceutical Limited.

The global generic musculoskeletal disorders drugs market is expected to grow from $0.05 billion in 2022 to $0.06 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The generic musculoskeletal disorders drugs market is expected to grow to $0.07 billion in 2027 at a CAGR of 5.7%.

The generic musculoskeletal disorders drugs market consists of sales of analgesics, oral non-steroidal anti-inflammatory drugs (NSAIDs), opioids, anti-neuropathic pain medications, corticosteroids, and disease modifying anti-rheumatic drugs (DMARDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Generic musculoskeletal disorders drugs refer to the medication that plays a key role in managing musculoskeletal condition. They are used to relieve pain and stiffness in muscles and treat muscle spasms.

Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2022. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main treatment of generic musculoskeletal disorders drugs are medication, therapy, surgery, and others. Medication refers to a dose form with one or more active chemicals as well as potential inactive ones. These can be administered through oral, parenteral, and other routes for the treatment of osteoarthritis, rheumatoid arthritis, spondylarthritis, juvenile idiopathic arthritis, psoriatic arthritis, fibromyalgia, and other disorders. These are distributed via various channels such as hospital pharmacy, retail pharmacy, drug store, and online pharmacy.

The high prevalence of arthritis is expected to propel the growth of the generic musculoskeletal disorders drugs market going forward. Arthritis refers to the tenderness and swelling of joints along with the symptoms including joint pain and stiffness. Generic musculoskeletal disorders drugs help to relieve pain and stiffness in muscles and can treat muscle spasms in arthritis patients. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, by 2040, 78.4 million adults aged 18 years and older (25.9% of the total adult population) are expected to have doctor-diagnosed arthritis. Therefore, the high prevalence of arthritis is driving the growth of the generic musculoskeletal disorders drugs market.

Strategic partnerships are a key trend gaining popularity in the generic musculoskeletal disorders drugs market. Many companies operating in the generic musculoskeletal disorders drugs market are undergoing partnerships to strengthen their position in the market. For instance, in December 2020, PostEra, a US-based biotechnology company, partnered with Pfizer Inc., a US-based pharmaceutical and biotechnology corporation. This partnership aims to introduce advanced machine learning for drug discovery. Further, in February 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology corporation, partnered with Alex Therapeutics, a Sweden-based digital therapeutics company. This new strategic business relationship offers patients evidence-based, clinically verified, and tailored digital therapeutics.

In May 2020, Assertio Therapeutics Inc., a US-based specialty pharmaceutical company acquired Zyla Life Sciences for an undisclosed deal amount. With this acquisition, Assertio Therapeutics aims to focus on neurology, inflammation, and pain products, an assortment of non-steroidal anti-inflammatory medicines that are distinct. Zyla Life Sciences is a US-based producer and distributor of anti-inflammatory and pain medications operating in the generic musculoskeletal disorders drugs market.

The countries covered in the generic musculoskeletal disorders drugs market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The generic musculoskeletal disorders drugs market research report is one of a series of new reports from The Business Research Company that provides generic musculoskeletal disorders drugs market statistics, including generic musculoskeletal disorders drugs industry global market size, regional shares, competitors with a generic musculoskeletal disorders drugs market share, detailed generic musculoskeletal disorders drugs market segments, market trends and opportunities, and any further data you may need to thrive in the generic musculoskeletal disorders drugs industry. This generic musculoskeletal disorders drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Generic Musculoskeletal Disorders Drugs Market Characteristics

3. Generic Musculoskeletal Disorders Drugs Market Trends And Strategies

4. Generic Musculoskeletal Disorders Drugs Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Generic Musculoskeletal Disorders Drugs Market
• 4.2. Ukraine-Russia War Impact On Generic Musculoskeletal Disorders Drugs Market
• 4.3. Impact Of High Inflation On Generic Musculoskeletal Disorders Drugs Market

5. Generic Musculoskeletal Disorders Drugs Market Size And Growth

• 5.1. Global Generic Musculoskeletal Disorders Drugs Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Generic Musculoskeletal Disorders Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Generic Musculoskeletal Disorders Drugs Market Segmentation

• 6.1. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Medication
• Therapy
• Surgery
• Other Treatment Types
• 6.2. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Oral
• Parenteral
• Other Routes
• 6.3. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Disorder Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Osteoarthritis
• Rheumatoid Arthritis
• Spondylarthritis
• Juvenile Idiopathic Arthritis
• Psoriatic Arthritis
• Fibromyalgia
• Other Disorder Types
• 6.4. Global Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Drug Store
• Online Pharmacy

7. Generic Musculoskeletal Disorders Drugs Market Regional And Country Analysis

• 7.1. Global Generic Musculoskeletal Disorders Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Generic Musculoskeletal Disorders Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market

• 8.1. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Generic Musculoskeletal Disorders Drugs Market

• 9.1. China Generic Musculoskeletal Disorders Drugs Market Overview
• 9.2. China Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Generic Musculoskeletal Disorders Drugs Market

• 10.1. India Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Generic Musculoskeletal Disorders Drugs Market

• 11.1. Japan Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Generic Musculoskeletal Disorders Drugs Market

• 12.1. Australia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Generic Musculoskeletal Disorders Drugs Market

• 13.1. Indonesia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Generic Musculoskeletal Disorders Drugs Market

• 14.1. South Korea Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Generic Musculoskeletal Disorders Drugs Market

• 15.1. Western Europe Generic Musculoskeletal Disorders Drugs Market Overview
• 15.2. Western Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Generic Musculoskeletal Disorders Drugs Market

• 16.1. UK Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Generic Musculoskeletal Disorders Drugs Market

• 17.1. Germany Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Generic Musculoskeletal Disorders Drugs Market

• 18.1. France Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Generic Musculoskeletal Disorders Drugs Market

• 19.1. Eastern Europe Generic Musculoskeletal Disorders Drugs Market Overview
• 19.2. Eastern Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Generic Musculoskeletal Disorders Drugs Market

• 20.1. Russia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Generic Musculoskeletal Disorders Drugs Market

• 21.1. North America Generic Musculoskeletal Disorders Drugs Market Overview
• 21.2. North America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Generic Musculoskeletal Disorders Drugs Market

• 22.1. USA Generic Musculoskeletal Disorders Drugs Market Overview
• 22.2. USA Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Generic Musculoskeletal Disorders Drugs Market

• 23.1. South America Generic Musculoskeletal Disorders Drugs Market Overview
• 23.2. South America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Generic Musculoskeletal Disorders Drugs Market

• 24.1. Brazil Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Generic Musculoskeletal Disorders Drugs Market

• 25.1. Middle East Generic Musculoskeletal Disorders Drugs Market Overview
• 25.2. Middle East Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Generic Musculoskeletal Disorders Drugs Market

• 26.1. Africa Generic Musculoskeletal Disorders Drugs Market Overview
• 26.2. Africa Generic Musculoskeletal Disorders Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Generic Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Generic Musculoskeletal Disorders Drugs Market Competitive Landscape And Company Profiles

• 27.1. Generic Musculoskeletal Disorders Drugs Market Competitive Landscape
• 27.2. Generic Musculoskeletal Disorders Drugs Market Company Profiles
  • 27.2.1. Pfizer Inc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Sanofi S.A.
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Eli Lilly And Company
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. Ampio Pharmaceuticals Inc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Amgen Inc.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Generic Musculoskeletal Disorders Drugs Market

29. Generic Musculoskeletal Disorders Drugs Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer